peroxynitrous acid has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alganga, H; Almabrouk, TAM; Currie, S; Ewart, MA; Hubanova, P; Katwan, OJ; Kennedy, S; Ugusman, A; Vishwanath, A | 1 |
| Chatham, JC; Chen, YF; Gong, K; Hilgers, RH; Oparil, S; Xing, D | 1 |
2 other study(ies) available for peroxynitrous acid and Aortic Diseases
| Article | Year |
|---|---|
Changes in IP3 Receptor Expression and Function in Aortic Smooth Muscle of Atherosclerotic Mice.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Calcium Signaling; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Inositol 1,4,5-Trisphosphate Receptors; Male; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Peroxynitrous Acid; Phenotype; Potassium Channels, Voltage-Gated; Vasodilation; Vasodilator Agents | 2017 |
Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction.
Topics: Acetylglucosamine; Acylation; Animals; Aorta, Thoracic; Aortic Diseases; beta-N-Acetylhexosaminidases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Immunohistochemistry; Inflammation; Inflammation Mediators; Male; Myography; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxynitrous Acid; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Time Factors; Tissue Culture Techniques; Tumor Necrosis Factor-alpha; Tyrosine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2012 |